Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description adds substantial behavioral context beyond the annotations: it explains the specific data pulled for each type (revenue, net income, etc. for companies; adverse events, approvals, trials for drugs), fiscal year handling, sorting by primary metric, and inclusion of citation URIs. All annotations (readOnly, openWorld, idempotent) are consistent and the description enriches them.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and informative, with front-loaded trigger phrases and key behavioral details. While it is somewhat long, every sentence adds value. The structure is logical but could be slightly more streamlined by grouping related behaviors.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite lacking an output schema, the description adequately explains that the tool returns paired data with citation URIs and sorted results. It covers the main scenarios and data sources. However, it omits potential error cases (e.g., invalid tickers, insufficient entities) and does not specify the exact response format, which could aid agents further.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

With 100% schema coverage, the baseline is 3. The description adds meaning by explaining the type enum values, the meaning of values elements (tickers/CIKs vs drug names), and constraints like min/max items. It clarifies that for drugs, use generic names, which goes beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs side-by-side comparisons of 2-5 companies or drugs, specifying data sources (SEC EDGAR for companies, FAERS/FDA for drugs). It explicitly distinguishes from sequential single-pack lookups and mentions sibling tools like entity_profile, making the purpose unambiguous.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides explicit natural language triggers ('Compare X and Y', 'X vs Y', etc.) and advises preference over sequential lookups. It explains the type parameter and value constraints, offering clear context for when to use this tool, though it could explicitly state when not to use it (e.g., single entity queries).

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Multiple tool clusters are nearly indistinguishable: ask_pipeworx and ask_pipeworx_beta are explicitly documented as currently identical, scan_competitor_ai_presence is a thin wrapper over ai_visibility_check, and the five polymarket_* tools (edges, edge_tracker, arbitrage, fill_risk, kalshi_spread) share heavily overlapping edge-detection/fill-analysis concerns. entity_profile and recent_changes also both fan out to the same SEC/news/patents sources, so an agent must read full descriptions to avoid misselection.

Naming Consistency3/5

The dominant pattern is imperative verb_first (list_datasets, get_dataset, resolve_entity, validate_claim, scan_dependency, subscribe), but there are notable deviations: noun-phrase names like entity_profile, recent_alerts, recent_changes, bet_research, and deep_research; the ask_pipeworx brand family sits awkwardly beside get_/search_ verbs; and the polymarket_* prefix family forms yet another convention. Names are readable and mostly self-explanatory, but no single consistent scheme is followed.

Tool Count2/5

At 35 tools, this exceeds the 'too many (25+)' threshold, and the bloat is compounded by the server's nominal identity: despite being named 'Bpstat Pt' (Banco de Portugal statistics), only about 5 tools (list_domains, list_datasets, get_dataset, get_series_metadata) actually serve that domain. The other 30 tools span unrelated subsystems — Polymarket betting, npm dependency scanning, AI visibility audits, generic memory, and subscriptions — suggesting several products bundled into one server.

Completeness3/5

For the broader data-gateway interpretation, the lifecycle is well covered: discovery (discover_tools, suggest_questions), query (ask_pipeworx), grounded verification (ask_pipeworx_grounded, validate_claim), deep research (deep_research), profiles/comparisons (entity_profile, compare_entities), monitoring (recent_changes, subscribe/recent_alerts), and memory (remember/recall/forget). However, for the nominal Bpstat statistical domain there is no keyword search over series or datasets — navigation requires knowing domain/dataset ids in advance — and the extreme scatter across unrelated domains leaves each subsystem only partially developed.